'Randomized phase' diaporamas de présentation

1.09k views • 66 slides

Gastrointestinal Colorectal Cancer Poster Discussion Session #3523 - #3528

600 views • 42 slides

EORTC STBSG

EORTC STBSG. Ongoing clinical trials Venice, November 4th. A RANDOMIZED STUDY COMPARING NEOADJUVANT CHEMOTHERAPY ETOPOSIDE + IFOSFAMIDE + ADRIAMYCIN (EIA) COMBINED WITH REGIONAL HYPERTHERMIA (RHT) VS. NEOADJUVANT CHEMOTHERAPY ALONE

570 views • 27 slides

Hematology Highlights ASCO 2011

Hematology Highlights ASCO 2011. Don M Benson Jr MD PhD The Ohio State University Comprehensive Cancer Center. Overview. Acute leukemia Chronic lymphocytic leukemia Lymphoma Myeloma.

357 views • 27 slides

Does the Chemo Backbone Matter? Wells Messersmith, MD, FACP Professor

Does the Chemo Backbone Matter? Wells Messersmith, MD, FACP Professor Director, Gastrointestinal Medical Oncology Program Co-Head , Division of Medical Oncology Program co-Leader, Developmental Therapeutics March 2014. Conflict of Interest:

487 views • 25 slides

Ian M. Carrese PA-S2 South University PA Program July 21, 2012

365 views • 22 slides

CHEMOTHERAPY AND BLADDER CANCER

460 views • 12 slides

316 views • 10 slides

Authors: de Wit R. et al, ASCO 2011 Abstract: 4509 Reviewed by: Dr. Lori Wood

A randomized phase III study comparing paclitaxel-BEP (T-BEP) to standard BEP in patients with intermediate prognosis germ cell cancer (GCC): An intergroup study of EORTC, German TCSG/AUO, MRC, and Spanish GCC group (EORTC 30983). Authors: de Wit R. et al, ASCO 2011 Abstract: 4509

199 views • 8 slides

151 views • 4 slides